Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter 10 January 2025
The Evolving Landscape of Atrial Fibrillation Ablation: VARIPULSE™ Launches in European Hospitals 22 October 2024
Johnson & Johnson MedTech receives CE Mark for OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias 30 August 2024
Biosense Webster Completes Enrollment of Omny-IRE Clinical Trial Investigating the OMNYPULSE™ Large-tip Focal Pulsed Field Ablation Catheter 26 August 2024
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting 17 May 2024
First Look at Data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH™ SF Platform for Atrial Fibrillation Presented at EHRA Congress 09 April 2024
Biosense Webster inspIRE clinical study demonstrates 80% freedom from atrial arrhythmia recurrence at 12 months 26 March 2024
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform 29 February 2024
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan 09 January 2024